FR2877573B1 - Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues - Google Patents

Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues

Info

Publication number
FR2877573B1
FR2877573B1 FR0411810A FR0411810A FR2877573B1 FR 2877573 B1 FR2877573 B1 FR 2877573B1 FR 0411810 A FR0411810 A FR 0411810A FR 0411810 A FR0411810 A FR 0411810A FR 2877573 B1 FR2877573 B1 FR 2877573B1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
different forms
new pharmaceutical
drug accumulation
uses therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0411810A
Other languages
English (en)
Other versions
FR2877573A1 (fr
Inventor
Mario Sanchez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debussy Holding SA
Original Assignee
Debussy Holding SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0411810A priority Critical patent/FR2877573B1/fr
Application filed by Debussy Holding SA filed Critical Debussy Holding SA
Priority to CNA2005800448695A priority patent/CN101087603A/zh
Priority to PCT/FR2005/002775 priority patent/WO2006048560A2/fr
Priority to EP05816959A priority patent/EP1814542A2/fr
Priority to AU2005300424A priority patent/AU2005300424A1/en
Priority to RU2007120707/15A priority patent/RU2007120707A/ru
Priority to JP2007539613A priority patent/JP2008519016A/ja
Priority to US11/666,981 priority patent/US20080090895A1/en
Priority to CA002586277A priority patent/CA2586277A1/fr
Publication of FR2877573A1 publication Critical patent/FR2877573A1/fr
Application granted granted Critical
Publication of FR2877573B1 publication Critical patent/FR2877573B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FR0411810A 2004-11-05 2004-11-05 Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues Expired - Fee Related FR2877573B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0411810A FR2877573B1 (fr) 2004-11-05 2004-11-05 Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues
PCT/FR2005/002775 WO2006048560A2 (fr) 2004-11-05 2005-11-07 Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues
EP05816959A EP1814542A2 (fr) 2004-11-05 2005-11-07 Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues
AU2005300424A AU2005300424A1 (en) 2004-11-05 2005-11-07 Novel pharmaceutical compositions and the uses thereof for controlling the different forms of addiction to drugs
CNA2005800448695A CN101087603A (zh) 2004-11-05 2005-11-07 新型药物组合物及其用于对抗不同形式的药物成瘾的用途
RU2007120707/15A RU2007120707A (ru) 2004-11-05 2005-11-07 Новые фармацевтические композиции и их применение для борьбы против различных форм привыкания к лекарствам
JP2007539613A JP2008519016A (ja) 2004-11-05 2005-11-07 新規な医薬品組成物および様々な形の薬物嗜癖を制御するためのそれらの使用
US11/666,981 US20080090895A1 (en) 2004-11-05 2005-11-07 Novel Pharmaceutical Composition And Their Uses Thereof For Controlling The Different Forms Of Addiction To Drugs
CA002586277A CA2586277A1 (fr) 2004-11-05 2005-11-07 Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0411810A FR2877573B1 (fr) 2004-11-05 2004-11-05 Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues

Publications (2)

Publication Number Publication Date
FR2877573A1 FR2877573A1 (fr) 2006-05-12
FR2877573B1 true FR2877573B1 (fr) 2007-02-02

Family

ID=34953312

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0411810A Expired - Fee Related FR2877573B1 (fr) 2004-11-05 2004-11-05 Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues

Country Status (9)

Country Link
US (1) US20080090895A1 (fr)
EP (1) EP1814542A2 (fr)
JP (1) JP2008519016A (fr)
CN (1) CN101087603A (fr)
AU (1) AU2005300424A1 (fr)
CA (1) CA2586277A1 (fr)
FR (1) FR2877573B1 (fr)
RU (1) RU2007120707A (fr)
WO (1) WO2006048560A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007096489A1 (fr) * 2006-02-17 2007-08-30 Trimaran Limited Nouvelles compositions pharmaceutiques destinees a optimiser des traitements de substitution et elargir la pharmacopee au traitement global des addictions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4129655A (en) * 1976-04-26 1978-12-12 Ciba-Geigy Corporation Neuroleptic 2-piperidinoalkyl-1,4-benzodioxans
US4412999A (en) * 1982-04-14 1983-11-01 Merck & Co., Inc. Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
CA2250155A1 (fr) * 1996-03-25 1997-10-02 Eli Lilly And Company Methode d'anesthesie
MXPA04007936A (es) * 2002-02-15 2004-11-26 Upjohn Co Compuestos de aril-sustituidos para el tratamiento de enfermedades.

Also Published As

Publication number Publication date
CA2586277A1 (fr) 2006-05-11
WO2006048560A2 (fr) 2006-05-11
RU2007120707A (ru) 2008-12-10
US20080090895A1 (en) 2008-04-17
AU2005300424A1 (en) 2006-05-11
WO2006048560A3 (fr) 2006-07-06
CN101087603A (zh) 2007-12-12
JP2008519016A (ja) 2008-06-05
EP1814542A2 (fr) 2007-08-08
FR2877573A1 (fr) 2006-05-12

Similar Documents

Publication Publication Date Title
FR14C0020I1 (fr) Compositions pharmaceutiques contenant du fentanyl pour application nasale
EP1765379A4 (fr) Compositions pharmaceutiques de co-cristal et methodes d'utilisation associees
ZA200702536B (en) Low oil emulsion compositions for delivering taxolds and other insoluble drugs
ZA200504239B (en) Pharmaceutical suspension composition
ZA200809002B (en) Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
IL183583A0 (en) Quinazoline derivatives and pharmaceutical compositions containing the same
DE602005004039D1 (de) Nicht-peptidische bradykinin-antagonisten und pharmazeutische zusammensetzungen daraus
AP2008004671A0 (en) Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
IL208497A0 (en) Pharmaceutical compositions containing erythropoietin and derivatives thereof
FR2901273B1 (fr) Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant
FR2900823B1 (fr) Nouvelle forme d'administration du racecadotril.
IL183986A0 (en) Pharmaceutical compounds and compositions
FR2838648B1 (fr) Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
FR2888748B1 (fr) Composes neuroprotecteurs et compositions pharmaceutiques les comprenant
MA28862B1 (fr) Composition pharmaceutique sous forme de comprime a residence gastrique contenant un principe actif
EP1968609A4 (fr) Compositions pharmaceutiques et procedes pour l'utilisation de composes sulfhydryles hautement lipophiles
MA28603B1 (fr) Composition pharmaceutique antimycobacterienne
HK1103958A1 (en) Pharmaceutical composition of piperazine derivatives
FR2877573B1 (fr) Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues
IL188848A (en) A transient receptor antagonist (TRPVI) i, a pharmaceutical preparation containing it for the treatment of related diseases and conditions.
FR2869539B1 (fr) Compositions pharmaceutiques pour la prevention et le traitement de l'atherosclerose
HK1094153A1 (en) Nasal pharmaceutical composition of piribedil
MA28606B1 (fr) Dérivés d'indazole et d'indolone et leur utilisation comme agents pharmaceutiques
IL189827A0 (en) Pharmaceutical dosage forms and compositions comprising lecoztan
ITMI20041447A1 (it) Composizione farmaceutica comprendente gabapentina

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20120731